This study demonstrated that liraglutide, a type of GLP-1 RA, can stimulate the expression of pulmonary ACE2 and Angiotensin (1-7) [A(1-7)], thereby reversing the imbalance within the renin-angiotensin system (RAS) in rats with type 1 diabetes mellitus (T1DM). The gene discussed is GLP1R; the disease is diabetes mellitus.